Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share - Narrative (Details)

v3.23.3
Loss Per Share - Narrative (Details)
9 Months Ended
Oct. 20, 2021
shares
Jun. 17, 2021
Sep. 30, 2023
tranche
$ / shares
shares
Dec. 31, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration period     5 years  
Number of tranches | tranche     3  
Common stock, shares outstanding (in shares) | shares     18,750,000  
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of trading days for determining the value per share 20 days 20 days 20 days  
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of trading days for determining the value per share 30 days 30 days 30 days  
Share-based Payment Arrangement, Tranche One        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average grant-date fair value, granted (dollars per share)     $ 12.00  
Share-based Payment Arrangement, Tranche Two        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average grant-date fair value, granted (dollars per share)     14.00  
Share-based Payment Arrangement, Tranche Three        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average grant-date fair value, granted (dollars per share)     $ 16.00  
Class A Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Class of warrant or right outstanding (in shares) | shares     27,249,779  
Warrant exercise price (in dollars per share)     $ 11.50  
Common stock, shares outstanding (in shares) | shares 18,750,000   217,960,513 200,298,834